Wikipedia -WSS

Wikipedia

author：explore 2025-10-02 19:20:15 - browse：73479

Adam's take main illustration — Molly Ferguson/STAT

The Food and Drug Administration should halt Cassava Sciences’ ongoing clinical trials in Alzheimer’s disease. That, and other thoughts on the fallout from the City University of New York investigation that raised serious doubts about the science underpinning the company’s experimental drug simufilam.

Patient safety is paramount to the FDA, so stopping Cassava’s two Phase 3 studies is the ethically correct thing to do.The FDA has the power to place clinical holds on experimental drugs when there’s evidence of an unacceptable safety risk to study participants. Simufilam doesn’t appear to be toxic. It’s not causing dangerous side effects. But study participants can also be harmed when they volunteer for a clinical trial based on false or misleading information about a drug’s potential efficacy.

The CUNY committee charged with investigating Cassava’s principal scientific collaborator, the neuroscientist Hoau-Yan Wang, could not definitively prove that Wang faked simufilam data, but that’s only because he refused to turn over original data and primary research records that the committee had requested to examine. Wang also claimed that boxes of research records relevant to the investigation were thrown away. The investigative report was first made public last week in the journal Science.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

hotspot

WSS

After Sarepta trial failure, Duchenne families brace for more debate

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Hospitals owned by private equity see complications spike 25%

Gene therapy’s promise and the high cost of hope

Keeping primary care docs in field isn't impossible, says AAFP CEO

Bill would allow buprenorphine prescription for addiction via telehealth

Wikipedia

Wikipedia

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Violet CEO on training clinicians to promote more inclusive care

Trump demands the U.S. pay no more for drugs than other countries … again

Christmas in the PICU brings some surprising joy

Supreme Court strikes down use of affirmative action

Violet CEO on training clinicians to promote more inclusive care

Hepatitis C has a cure — but many Americans still lack access to it

After Sarepta trial failure, Duchenne families brace for more debate

DIEP, the 'gold standard' of breast reconstruction, is under threat

Why health records don't always know when patients are dead

entertainment

Humans aren't the only ones with an imagination. Rats have it too

CRISPR gene editing developments we’re watching in 2024

Live blog: Hearing on CRISPR

How to convince healthy people to buy insurance

Life sciences investors close nearly $6 billion in new funds

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

entertainment

hotspot

leisure time

leisure time